Impact of oncology drug shortages on patient therapy: Unplanned treatment changes

Journal of Oncology Practice

Volumn 9, Issue 4, 2013, Pages

  Becker, Daniel J ^a   Talwar, Sumit ^a   Levy, Benjamin P ^a   Thorn, Molly ^a   Roitman, Janna ^a   Blum, Ronald H ^a   Harrison, Louis B ^a   Grossbard, Michael L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOXANTRONE; NAVELBINE; PACLITAXEL; VINCRISTINE;

ADULT; AGED; ARTICLE; BODY SURFACE; CANCER PATIENT; CANCER THERAPY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHYSICIAN; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COST-BENEFIT ANALYSIS; DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT CARE; PHYSICIANS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84887113252     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000799     Document Type: Article

References (13)

1. US Food and Drug Administration: FDA and manufacturers work to prevent drug shortages. http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm257746.htm
2. Allen J: Chemo drug Taxol shortage puts cancer patients at risk. ABC News [serial online] 2011. http://abcnews.go.com/Health/ CancerPreventionAndTreatment/chemo-drug-taxol-shortage-leaves-doctors- scrambling-cancer/story?id=13906891
3. Harris G: U.S. scrambling to ease shortage of vital medicine. The New York Times, 2011, p A1
4. BaumerAM, Clark AM, Witmer DR, et al: National survey of the impact of drug shortages in acute care hospitals. Am J Health Syst Pharm 61:2015-2022, 2004
5. Kaakeh R, Sweet BV, Reilly C, et al.: Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm 68:1811-1819, 2011
6. Jensen V, Rappaport BA: The reality of drug shortages - The case of the injectable agent propofol. N Engl J Med 363(9): 806-807, 2010
7. Gatesman ML, Smith TJ: The shortage of essential chemotherapy drugs in the United States. N Engl J Med 365:1653-1655, 2011
8. Haninger K, Jessup A, Koehler K: Economic analysis of the causes of the drug shortages, 2011, http://aspe.hhs.gov/sp/reports/2011/DrugShortages/ib.pdf
9. ASHP Expert Panel on Drug Product Shortages, Fox ER, Birt A, et al.: ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm 66:1399-1406, 2009
10. Fox ER, Tyler LS: Managing drug shortages: Seven years' experience at one health system. Am J Health Syst Pharm 60:245-253, 2003
11. Johnson PE: Drug shortages: Impact and strategies. J Natl Compr Canc Netw 9:815-819, 2011
12. Cherici C: Navigating drug shortages in American healthcare: A Premier Healthcare Alliance analysis. http://www.premierinc.com/about/news/11-mar/drug- shortage-white-paper-3-28-11.pdf
13. Havrilesky LJ, Garfield CF, Barnett J.C., et al.: Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer. Gynecol Oncol 125: 631-634, 2012